Kyowa Kirin and Kura Oncology have begun a Japanese Phase II registrational study of ziftomenib in adult patients with r/r...
GE HealthCare has dosed the first patient in its Phase II/III LUMINA clinical trial for the investigational manganese-based MRI contrast...
CatalYm has commenced dosing the first subject in its Phase II/III VINCIT trial, assessing the safety and efficacy of its...
Cumberland Pharmaceuticals has agreed to sell its branded commercial drug portfolio to Canada-based Apotex for $100m in cash.The post Cumberland...
Philips has received the US FDA 510(k) clearance for its Rembra platform of scanning systems, which covers the Rembra CT,...
ModeX Therapeutics has started dosing patients with its tetraspecific T-cell engager, MDX2003, for relapsed or refractory B-cell lymphoma.The post ModeX...
MSD and Google Cloud have formed a multi-year partnership, investing up to $1bn, to advance agentic AI enterprise transformation.The post...
Artera has secured CE marking under the EU IVDR for its ArteraAI Prostate Biopsy and Breast Cancer assays, expanding the...
Roche has reported new findings from the Phase III METEOROID trial of Enspryng in adults and adolescents with MOGAD.The post...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.